Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
Completed
GlaxoSmithKline
Phase 2
2004-09-01
A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol
gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
Completed
University of Utah
Phase 2
2004-09-01
A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol
gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
Terminated
University Hospitals Cleveland Medical Center
N/A
2007-05-01
The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment
modifies UVB laser light response resulting in increased cell death compared to UVB laser
light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid
prior to UVB laser light exposure selectively effects various T cell functions; 3) to
determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those
changes with immuno-histochemical changes in the skin; and 4) to determine if single high
dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid
influences T cell changes
Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
Terminated
VA Office of Research and Development
N/A
2007-05-01
The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment
modifies UVB laser light response resulting in increased cell death compared to UVB laser
light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid
prior to UVB laser light exposure selectively effects various T cell functions; 3) to
determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those
changes with immuno-histochemical changes in the skin; and 4) to determine if single high
dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid
influences T cell changes
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
